|
US6572862B1
(en)
|
1989-11-08 |
2003-06-03 |
Baylor College Of Medicine |
Methods and reagents to detect and characterize Norwalk and related viruses
|
|
AU1893592A
(en)
|
1991-03-25 |
1992-10-21 |
Board Of Trustees Of The Leland Stanford Junior University |
Norwalk virus human gastroenteritis agent and molecular cloning of corresponding cdnas
|
|
AU683211B2
(en)
|
1992-04-08 |
1997-11-06 |
United States of America as represented by The Secretary Department of Health and Human Services, The |
Wild-type measles virus glycoproteins: vaccine and detection method therefor
|
|
WO1994005700A2
(en)
|
1992-09-07 |
1994-03-17 |
Baylor College Of Medicine |
Methods and reagents to detect and characterize norwalk and related viruses
|
|
KR100310510B1
(ko)
|
1993-03-23 |
2002-07-04 |
장 스테판느 |
3-0-탈아세틸화모노포스포릴지질a를함유하는백신조성물
|
|
US5788970A
(en)
|
1994-03-29 |
1998-08-04 |
The University Of Maryland College Park |
Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
|
|
ES2264126T3
(es)
|
1994-05-16 |
2006-12-16 |
MERCK & CO., INC. |
Vacunas contra el papilomavirus.
|
|
US5645051A
(en)
|
1995-04-21 |
1997-07-08 |
Dura Pharmaceuticals, Inc. |
Unit dose dry powder inhaler
|
|
US5861241A
(en)
|
1995-08-16 |
1999-01-19 |
University Of Massachusetts |
Monoclonal antibodies for detecting Norwalk virus
|
|
GB9525083D0
(en)
|
1995-12-07 |
1996-02-07 |
Danbiosyst Uk |
Vaccine compositions
|
|
US5834015A
(en)
*
|
1996-09-11 |
1998-11-10 |
Albany Medical College |
Protein-lipid vesicles and autogenous vaccine comprising the same
|
|
US5953727A
(en)
|
1996-10-10 |
1999-09-14 |
Incyte Pharmaceuticals, Inc. |
Project-based full-length biomolecular sequence database
|
|
US6491919B2
(en)
|
1997-04-01 |
2002-12-10 |
Corixa Corporation |
Aqueous immunologic adjuvant compostions of monophosphoryl lipid A
|
|
WO1998044944A2
(en)
|
1997-04-08 |
1998-10-15 |
Merck & Co., Inc. |
Stabilized human papillomavirus formulations
|
|
AU750702B2
(en)
|
1997-05-01 |
2002-07-25 |
Chiron Corporation |
Use of virus-like particles as adjuvants
|
|
US20040265377A1
(en)
|
1997-10-27 |
2004-12-30 |
Harry Seager |
Solid dispersing vaccine composition for oral delivery
|
|
EP1105466B1
(en)
|
1998-08-14 |
2006-04-26 |
Merck & Co., Inc. |
Process for purifying human papillomavirus virus-like particles
|
|
CA2354444A1
(en)
|
1998-12-17 |
2000-06-22 |
Merck & Co., Inc. |
Synthetic virus-like particles with heterologous epitopes
|
|
ATE413188T1
(de)
*
|
1999-02-05 |
2008-11-15 |
Merck & Co Inc |
Menschliche papillomavirus impfstoff- formulierungen
|
|
CA2375337C
(en)
|
1999-06-22 |
2012-09-25 |
Naokazu Takeda |
Srsv detection kit
|
|
JP2002020399A
(ja)
|
2000-07-10 |
2002-01-23 |
Osaka Prefecture |
ノルウォークウイルス（ｎｖ）を認識するモノクローナル抗体
|
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
|
WO2003068804A2
(en)
|
2002-02-14 |
2003-08-21 |
Novavax, Inc. |
Novel insect cell line
|
|
GB0206360D0
(en)
|
2002-03-18 |
2002-05-01 |
Glaxosmithkline Biolog Sa |
Viral antigens
|
|
GB0206359D0
(en)
|
2002-03-18 |
2002-05-01 |
Glaxosmithkline Biolog Sa |
Viral antigens
|
|
EP1494651A4
(en)
|
2002-04-11 |
2010-10-13 |
Medimmune Vaccines Inc |
PRESERVATION OF BIOACTIVE MATERIALS WITH FREEZZED FOAM
|
|
GB0302218D0
(en)
|
2003-01-30 |
2003-03-05 |
Chiron Sri |
Vaccine formulation & Mucosal delivery
|
|
JP2006507800A
(ja)
|
2002-06-07 |
2006-03-09 |
ラージ・スケール・バイオロジー・コーポレイション |
可撓性ワクチンアセンブリおよびワクチン送達プラットフォーム
|
|
ATE489969T1
(de)
|
2002-06-20 |
2010-12-15 |
Cytos Biotechnology Ag |
Verpackte virusartige partikel in kombination mit cpg zur verwendung als adjuvantien mit allergenen. herstellungsverfahren und verwendung
|
|
CA2514667C
(en)
|
2003-01-30 |
2013-01-08 |
Chiron Corporation |
Adjuvanted influenza vaccine
|
|
WO2004073652A2
(en)
|
2003-02-20 |
2004-09-02 |
Becton Dickinson And Company |
Powder formulations of recombinant staphylococcal enterotoxin b (rseb) made by atmospheric spray-freeze drying for improved vaccination
|
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
US7879338B2
(en)
|
2003-07-21 |
2011-02-01 |
Boyce Thompson Institute For Plant Research |
Vectors and methods for immunization against norovirus using transgenic plants
|
|
JP2007537137A
(ja)
|
2003-09-24 |
2007-12-20 |
モンタナ ステート ユニバーシティ |
ノロウィルスモノクローナル抗体及びペプチド
|
|
WO2005037223A2
(en)
|
2003-10-15 |
2005-04-28 |
Brigham And Women's Hospital, Inc. |
Methods and compositions for immunomodulation
|
|
US20050215501A1
(en)
|
2003-10-24 |
2005-09-29 |
Coley Pharmaceutical Group, Inc. |
Methods and products for enhancing epitope spreading
|
|
FR2863890B1
(fr)
|
2003-12-19 |
2006-03-24 |
Aventis Pasteur |
Composition immunostimulante
|
|
US7481997B1
(en)
|
2004-02-12 |
2009-01-27 |
Montana State University |
Snow mountain virus genome sequence, virus-like particles and methods of use
|
|
US20050260225A1
(en)
|
2004-05-18 |
2005-11-24 |
Goldberg Joanna B |
Intranasal recombinant Salmonella vaccine encoding heterologous polysaccharide antigens
|
|
CU23496A1
(es)
|
2004-09-03 |
2010-02-23 |
Ct Ingenieria Genetica Biotech |
Composición vacunal contra el virus de la hepatitis c
|
|
SG156666A1
(en)
|
2004-10-20 |
2009-11-26 |
Acambis Inc |
Vaccines against japanese encephalitis virus and west nile virus
|
|
GB0428394D0
(en)
|
2004-12-24 |
2005-02-02 |
Chiron Srl |
Saccharide conjugate vaccines
|
|
WO2006074303A2
(en)
|
2005-01-05 |
2006-07-13 |
Philadelphia Health And Education Corporation |
Delivery vehicles, bioactive substances and viral vaccines
|
|
US8168771B2
(en)
|
2005-01-31 |
2012-05-01 |
The Johns Hopkins University |
Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants
|
|
JP2008530245A
(ja)
|
2005-02-18 |
2008-08-07 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド |
尿路病原性菌株由来の抗原
|
|
ES2424229T3
(es)
|
2005-03-18 |
2013-09-30 |
Cytos Biotechnology Ag |
Proteínas de fusión de alérgenos de gato y utilización de las mismas
|
|
CA2608515A1
(en)
|
2005-06-01 |
2007-05-10 |
Dow Global Technolgies Inc. |
Production of multivalent virus like particles
|
|
EP1736538A1
(en)
|
2005-06-21 |
2006-12-27 |
Cytos Biotechnology AG |
Process for the preparative purification of virus-like-particles (VLPs)
|
|
WO2007081447A2
(en)
|
2005-11-22 |
2007-07-19 |
Novartis Vaccines And Diagnostics, Inc. |
Norovirus and sapovirus antigens
|
|
JP2007145775A
(ja)
|
2005-11-29 |
2007-06-14 |
Falco Life Science:Kk |
ノロウイルスｇｉの高感度検出方法
|
|
US20080029915A1
(en)
*
|
2006-08-02 |
2008-02-07 |
Courtoy Nv |
Rotary tablet press
|
|
EP2601969B1
(en)
*
|
2006-09-29 |
2016-03-30 |
Takeda Vaccines, Inc. |
Norovirus vaccine formulations
|
|
JP2011506264A
(ja)
|
2006-12-06 |
2011-03-03 |
ノバルティス アーゲー |
インフルエンザウイルスの４つの株に由来する抗原を含むワクチン
|
|
CA2683977C
(en)
*
|
2007-03-14 |
2017-04-25 |
Ligocyte Pharmaceuticals, Inc. |
A method of norovirus virus-like particle purification comprising ion exchange chromatography
|
|
WO2009033229A1
(en)
|
2007-09-12 |
2009-03-19 |
Australian Centre For Plant Functional Genomics Pty Ltd |
Plant seed active transcriptional control sequences
|
|
US20100266636A1
(en)
|
2007-09-18 |
2010-10-21 |
Ligocyte Pharmaceuticals, Inc. |
Method of conferring a protective immune response to norovirus
|
|
CN104740624B
(zh)
*
|
2007-09-18 |
2018-04-24 |
武田疫苗股份有限公司 |
赋予针对诺如病毒的保护性免疫应答的疫苗
|
|
JP5852883B2
(ja)
|
2008-08-08 |
2016-02-03 |
タケダ ワクチン，インコーポレイテッド |
交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子
|
|
CA2750321A1
(en)
*
|
2009-01-22 |
2010-07-29 |
Pharmathene, Inc. |
Stable vaccine compositions and methods of use
|
|
WO2010092476A1
(en)
*
|
2009-02-10 |
2010-08-19 |
Novartis Ag |
Influenza vaccine regimens for pandemic-associated strains
|
|
US20110070260A1
(en)
|
2009-09-09 |
2011-03-24 |
Baric Ralph S |
Multivalent Immunogenic Compositions Against Noroviruses and Methods of Use
|
|
JP2013517773A
(ja)
|
2010-01-21 |
2013-05-20 |
リゴサイト ファーマスーティカルズ，インコーポレイテッド |
カリシウイルスウイルス様粒子上の標的化異種抗原提示
|
|
CN107029223A
(zh)
*
|
2010-05-26 |
2017-08-11 |
西莱克塔生物科技公司 |
合成纳米载体联合疫苗
|
|
PH12014500093A1
(en)
|
2011-07-11 |
2014-03-17 |
Takeda Vaccines Inc |
Parenteral norovirus vaccine formulations
|
|
JOP20130186B1
(ar)
|
2012-06-22 |
2021-08-17 |
Takeda Vaccines Montana Inc |
تنقية الجزيئات الشبيهة بالفيروسات
|
|
AU2016374497B2
(en)
|
2015-12-16 |
2022-03-10 |
The Walter And Eliza Hall Institute Of Medical Research |
Inhibition of cytokine-induced SH2 protein in NK cells
|
|
EP4338799A3
(en)
|
2016-10-18 |
2024-06-05 |
Regents of the University of Minnesota |
Tumor infiltrating lymphocytes and methods of therapy
|
|
SG11202010763VA
(en)
|
2018-05-03 |
2020-11-27 |
Univ Texas |
Natural killer cells engineered to express chimeric antigen receptors with immune checkpoint blockade
|
|
JP2021534074A
(ja)
|
2018-08-20 |
2021-12-09 |
タケダ ワクチン, インコーポレイテッドTakeda Vaccines, Inc. |
Ｖｌｐ製剤
|
|
AR117462A1
(es)
|
2018-12-20 |
2021-08-04 |
Takeda Vaccines Inc |
Vacuna contra norovirus, formulaciones y métodos
|
|
BR112021016046A2
(pt)
|
2019-02-15 |
2021-11-09 |
Editas Medicine Inc |
Células assassinas naturais modificadas (nk) para imunoterapia
|